Innovation-oriented growth companies, while risky, can deliver life-altering returns on capital for patient investors. Beam Therapeutics and Nano-X Imaging are angling to upend the status quo for mult
Nano-X Imaging now has regulatory approval to sell its device. As a result, it's signing agreements with customers around the world.
Investment bank analysts have predicted strong gains for a pair of stocks that have already risen more than 100% this year. Cord cutters are changing how viewers watch local sports, and fuboTV is well
Nano-X is marketing a different type of X-ray system. DermTech's Smart Sticker system could change dermatology.

Why Nanox Stock Skyrocketed 191% in May

04:18pm, Tuesday, 06'th Jun 2023
Nanox's medical device has been cleared by the FDA -- a key hurdle. The business is making headway in Africa, further fueling optimism.
Nano-X Imaging Ltd. (NNOX) reached a significant support level, and could be a good pick for investors from a technical perspective.

Is It Too Early to Invest In Nano-X Imaging?

09:45am, Thursday, 01'st Jun 2023
Nano-X stock has been red-hot this year, more than doubling in price. The business only generates modest revenue at this stage.

Why Shares of Nano-X Are Soaring Wednesday

12:54pm, Wednesday, 31'st May 2023
The company received clearance from the FDA earlier this month for its novel X-ray system. Nano-X's stock is still up more than 88% so far this year.
Two stocks in the healthcare sector have already doubled this year, and they could climb much higher, according to Wall Street. Viking Therapeutics is a clinical-stage biotech with an experimental tre
Nanox's business is expanding in Africa, which is bringing the company's vision closer to reality. The company needs to bolster its capabilities to mass-produce machines, but the small operation can a
NEVE ILAN, Israel, May 17, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX) will report its financial results for the first quarter ended March 31, 2023 before ma
Shares of CRISPR Therapeutics and Nanox have risen sharply in 2023. CRISPR Therapeutics is developing a slate of experimental gene therapies, and the first could earn approval this year.
One of the biggest names in healthcare now owns over 300,000 shares of Nanox. Nanox's medical device is now cleared by the FDA, paving the way for the company to take steps towards its long-term visio
The medical imaging technology company markets X-ray equipment powered by a low-voltage source of electrons. Traditional X-ray tubes use superheated filaments that require a lot more maintenance than
Nano-X is an under-the-radar medical device company that may very well transform healthcare for a billion people around the world. The stock went up 68% on May 1.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE